GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Inovio Biomedical Corporation (INO) [hlAlert]

Rating:
Buy INO
up 217.27 %

Inovio Biomedical Corporation (INO) rated Buy with price target $4 by Stifel

Posted on: Wednesday,  May 7, 2014  12:00 AM ET by Stifel

Stifel rated Buy Inovio Biomedical Corporation (NASDAQ: INO) on 05/07/2014, when the stock price was $2.20. Since
then, Inovio Biomedical Corporation has gained 217.27% as of 01/05/2016's recent price of $6.98.
If you would have followed this Stifel's recommendation on INO, you would have gained 217.27% of your investment in 608 days.

Inovio Biomedical Corporation (Inovio) is a San Diego-based biomedical company focused on the development of vaccines to prevent or treat cancers and chronic infectious diseases. Inovio develops deoxyribonucleic acid (DNA) delivery solutions based on electroporation, which uses brief, controlled electrical pulses to create temporary pores in cell membranes and enable increased cellular uptake of a useful biopharmaceutical. Once the DNA vaccine enters a cell, it can then express the proteins it was encoded to produce. Inovio has multiple systems designed to create different electroporation conditions for different applications consists of two documents: a pulse generator and an applicator that is inserted into selected tissue. The Company?s subsidiaries include Genetronics, Inc., Inovio AS and Inovio Asia Pte. Ltd. In June 2009, Inovio completed its merger with VGX Pharmaceuticals.

Stifel
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/7/2014 12:00 AM Buy
None
2.20 4.00
as of 10/17/2014
1 Week up  22.60 %
1 Month up  18.25 %
3 Months up  30.67 %
1 YTD up  459.54 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy